Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement

被引:20
|
作者
Goldman, Jennifer L. [1 ]
Chung, Wen-Hung [2 ]
Lee, Brian R. [3 ]
Chen, Chun-Bing [2 ]
Lu, Chun-Wei [2 ]
Hoetzenecker, Wolfram [4 ]
Micheletti, Robert [5 ]
Yasuda, Sally Usdin [6 ]
Margolis, David J. [5 ,7 ]
Shear, Neil H. [8 ,9 ]
Struewing, Jeffery P. [10 ]
Pirmohamed, Munir [11 ]
机构
[1] Childrens Mercy Hosp & Clin, Div Pediat Infect Dis & Clin Pharmacol, Dept Pediat, 2401 Gillham Rd, Kansas City, MO 64108 USA
[2] Chang Gung Univ, Drug Hypersensit Clin & Res Ctr, Keelung & Linkou Branches, Chang Gung Mem Hosp,Dept Dermatol,Coll Med, Taipei, Taiwan
[3] Childrens Mercy Hosp Clin, Div Hlth Serv & Outcomes Res, Kansas City, MO USA
[4] Univ Hosp Linz, Dept Dermatol, Linz, Austria
[5] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[6] US FDA, Silver Spring, MD USA
[7] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
[8] Sunnybrook Hlth Sci Ctr, Div Dermatol, Dept Med, Toronto, ON, Canada
[9] Univ Toronto, Toronto, ON, Canada
[10] NHGRI, Div Genom Med, NIH, Bethesda, MD USA
[11] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England
关键词
Causality assessment tool; Adverse drug reactions; Stevens-Johnson syndrome; Toxic epidermal necrolysis; EXPERT JUDGMENT;
D O I
10.1007/s00228-019-02670-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PurposeEstablishment of causality between drug exposure and adverse drug reactions (ADR) is challenging even for serious ADRs such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Several causality assessment tools (CAT) exist, but the reliability and validity of such tools is variable. The objective of this study was to compare the reliability and validity of existing ADR CATs on SJS/TEN cases.MethodsSeven investigators completed three CAT (ALDEN, Naranjo, Liverpool) for 10 SJS/TEN cases. Each CAT categorized the causality of 30 potential drugs as definite/very probable, probable, possible, or doubtful/unlikely. An additional reviewer provided expert opinion by designating the implicated drug(s) for each case. A Kappa score was generated to compare CAT responses both by method (reliability of all 7 reviewers, by CATs) and by reviewer (reliability of the 3 CAT, by reviewer). A c statistic was calculated to assess validity.ResultsInter-rater reliability by CAT was poor to fair: ALDEN 0.22, Naranjo 0.11, and Liverpool 0.12. Reliability was highest when causality classification was definite/very probable (0.16-0.41). Similarly, intra-rater reliability by reviewer was poor. When comparing the validity of the overall CAT to expert reviewer, area under the curve was highest for ALDEN (c statistic 0.65) as compared to Liverpool (0.55) or Naranjo (0.54).ConclusionAvailable CAT have poor reliability and validity for drug-induced SJS/TEN. Due to the importance of determining ADR causality for research, industry, and regulatory purposes, development of an enhanced tool that can incorporate data from immunological testing and pharmacogenetic results may strengthen CAT usefulness and applicability for drug-induced SJS/TEN.
引用
收藏
页码:1135 / 1141
页数:7
相关论文
共 50 条
  • [31] Toxic epidermal necrolysis and Stevens-Johnson syndrome
    Harr, Thomas
    French, Lars E.
    ORPHANET JOURNAL OF RARE DISEASES, 2010, 5
  • [32] Stevens-Johnson syndrome and toxic epidermal necrolysis in children
    Sotelo-Cruz, Norberto
    GACETA MEDICA DE MEXICO, 2012, 148 (03): : 265 - 275
  • [33] Aceclofenac induced Stevens-Johnson/toxic epidermal necrolysis overlap syndrome
    Ameen, Kaderthambi Hajamohideen Nooru
    Pinninti, Rakesh
    Jami, Swathi
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (01) : 69 - 71
  • [34] Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
    Maciejewska, Jolanta
    Jankowski, Marek
    Zegarska, Barbara
    Czajkowski, Rafal
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2014, 31 (03): : 194 - 196
  • [35] Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Induced by Fexofenadine
    Teo, S. L.
    Santosa, A.
    Bigliardi, P. L.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2017, 27 (03) : 191 - 193
  • [36] News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS']JS) and toxic epidermal necrolysis (TEN)
    Aide Martinez-Cabriales, Sylvia
    Gomez-Flores, Minerva
    Ocampo-Candiani, Jorge
    GACETA MEDICA DE MEXICO, 2015, 151 (06): : 777 - 787
  • [37] Clinical Features, Risk Factors, and Prognostic Markers of Drug-Induced Liver Injury in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
    Zhang, Zhibin
    Li, Sisi
    Zhang, Zhixiong
    Yu, Kaihui
    Duan, Xunxin
    Long, Lin
    Zhang, Shulan
    Jiang, Meiying
    Liu, Ougen
    INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (04) : 274 - 278
  • [38] Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children
    Finkelstein, Yaron
    Soon, Gordon S.
    Acuna, Patrick
    George, Mathew
    Pope, Elena
    Ito, Shinya
    Shear, Neil H.
    Koren, Gideon
    Shannon, Michael W.
    Garcia-Bournissen, Facundo
    PEDIATRICS, 2011, 128 (04) : 723 - 728
  • [39] A SYSTEM FOR THE RISK ASSESSMENT OF STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS APPEARANCE
    Zimenkovsky, A.
    Gorodnycha, O.
    PHARMACIA, 2013, 60 (04) : 31 - 36
  • [40] A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Chang, Hua-Ching
    Wang, Tsung-Jen
    Lin, Ming-Hsiu
    Chen, Ting-Jui
    BIOMEDICINES, 2022, 10 (09)